Literature DB >> 10214790

Severe combined immunodeficiency: otolaryngological presentation and management.

R M Stocks1, J W Thompson, J A Church, S Kun, E Simms.   

Abstract

In order to increase the awareness of otolaryngologists of severe combined immunodeficiency syndrome (SCIDS) so they may contribute to an earlier diagnosis of this disorder, we performed a retrospective chart review of a multicenter series from 2 children's hospital medical centers. Eighteen cases were identified, and 14 had an otolaryngological presentation. The average age of presentation was 3.3 months, and 72% were males. Most cases were inherited in an X-linked fashion. Five patients had thrush; 4 had recurrent otitis media. Other otolaryngological presentations included cough, mouth ulcers, pharyngitis, mastoiditis, and bilateral neck abscess. The most severe form of immunodeficiency, SCIDS is a rare condition that involves a disorder in both T and B cell functions. The manifestations involving the head and neck include recurrent upper respiratory tract infections, otitis media, thrush, oral ulcers, and abscesses. It is important that SCIDS be considered in any infant with recurrences of these common infections.

Entities:  

Mesh:

Year:  1999        PMID: 10214790     DOI: 10.1177/000348949910800415

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  3 in total

1.  Bilateral choanal atresia and paranasal sinus hypoplasia in an adult patient with hypogammaglobulinaemia.

Authors:  Hamid El-Sawy; M Azher Siddiq; Aubu Anbarasu
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-07-15       Impact factor: 2.503

Review 2.  Periodontal and other oral manifestations of immunodeficiency diseases.

Authors:  M E Peacock; R M Arce; C W Cutler
Journal:  Oral Dis       Date:  2016-10-10       Impact factor: 3.511

Review 3.  Signal-transduction defects in T cells.

Authors:  E Grunebaum; C M Roifman
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 10.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.